Robak T - Search Results

1

Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.

Wierzbowska A, Urbańska-Ryś H, Robak T. Wierzbowska A, et al. Among authors: robak t. Br J Haematol. 1999 May;105(2):412-9. Br J Haematol. 1999. PMID: 10233412 Free article.

2

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Robak T, Wierzbowska A, Błasińska-Morawiec M, Korycka A, Błoński JZ. Robak T, et al. Mediators Inflamm. 1999;8(6):277-86. doi: 10.1080/09629359990289. Mediators Inflamm. 1999. PMID: 10815616 Free PMC article.

3

Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.

Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T. Urbańska-Ryś H, et al. Among authors: robak t. Eur Cytokine Netw. 2000 Sep;11(3):443-51. Eur Cytokine Netw. 2000. PMID: 11022130 Free article.

4

[Cytokines in multiple myeloma].

Wierzbowska A, Robak T. Wierzbowska A, et al. Among authors: robak t. Pol Arch Med Wewn. 1998 Mar;99(3):245-53. Pol Arch Med Wewn. 1998. PMID: 9760813 Review. Polish. No abstract available.

5

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).

Wrzesień-Kuś A, Robak T, Lech-Marańda E, Wierzbowska A, Dmoszyńska A, Kowal M, Hołowiecki J, Kyrcz-Krzemień S, Grosicki S, Maj S, Hellmann A, Skotnicki A, Jedrzejczak W, Kuliczkowski K; Polish Adult Leukemia Group. Wrzesień-Kuś A, et al. Among authors: robak t. Eur J Haematol. 2003 Sep;71(3):155-62. doi: 10.1034/j.1600-0609.2003.00122.x. Eur J Haematol. 2003. PMID: 12930315 Clinical Trial.

6

Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma.

Robak T, Gora-Tybor J, Urbańska-Ryś H, Krykowski E. Robak T, et al. Leuk Lymphoma. 1999 Jan;32(3-4):359-63. doi: 10.3109/10428199909167397. Leuk Lymphoma. 1999. PMID: 10037034 Clinical Trial.

7

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.

Robak T, Błoński JZ, Urbańska-Ryś H, Błasińska-Morawiec M, Skotnicki AB. Robak T, et al. Leukemia. 1999 Apr;13(4):518-23. doi: 10.1038/sj.leu.2401368. Leukemia. 1999. PMID: 10214856

8

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.

Robak T, Urbańska-Ryś H, Strzelecka B, Krykowski E, Bartkowiak J, Bĺoński JZ, Kordek R, Warzocha K. Robak T, et al. Eur J Haematol. 2001 Nov-Dec;67(5-6):322-7. doi: 10.1034/j.1600-0609.2001.00592.x. Eur J Haematol. 2001. PMID: 11872081

9

The inhibitor of apoptosis protein family and its antagonists in acute leukemias.

Wrzesień-Kuś A, Smolewski P, Sobczak-Pluta A, Wierzbowska A, Robak T. Wrzesień-Kuś A, et al. Among authors: robak t. Apoptosis. 2004 Nov;9(6):705-15. doi: 10.1023/B:APPT.0000045788.61012.b2. Apoptosis. 2004. PMID: 15505413 Review.

10

Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemia.

Robak E, Jesionek-Kupnicka D, Robak T, Holub A, Wawrzyniak E, Bartkowiak J, Bednarek A, Constantinu M, Urbanska-Rys H. Robak E, et al. Among authors: robak t. Br J Dermatol. 2007 Sep;157(3):591-5. doi: 10.1111/j.1365-2133.2007.07923.x. Br J Dermatol. 2007. PMID: 17697078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters